airKAVE Proven to Deactivate Airborne SARS-CoV-2 in Independent Study

When the COVID-19 pandemic first emerged, one of the biggest challenges was understanding how to reduce the risks of airborne transmission. At KAVE Industries, our mission has always been to develop real-world plasma solutions that protect health, improve environments, and pave the way for a safer future. To ensure our technology lives up to that mission, we turned to independent third-party testing.

Why This Study Was Conducted

In March 2021, MRIGlobal, a leading independent laboratory, conducted controlled trials on the airKAVE Portable (Model #AH01) to evaluate its ability to deactivate aerosolized SARS-CoV-2, the virus responsible for COVID-19 .

The study was designed to measure how effectively the Plascide® plasma technology inside airKAVE neutralizes airborne viruses without relying on traditional filters.

How the Testing Worked

• Location: MRIGlobal’s high-containment BSL-3 laboratory in Kansas City, MO.
• Virus: SARS-CoV-2 strain USA-WA1/2020 — the same strain first isolated in Washington State early in the pandemic .
• Setup: A sealed Plexiglas aerosol chamber simulated a controlled indoor environment of about 370 liters (13 cubic feet).
• Device: The airKAVE Portable Model #AH01, powered by USB, recirculated air at 80–100 liters per minute through its plasma module.
• Process: Virus particles were aerosolized in the chamber, then samples were collected over one-hour intervals to measure how much viable virus remained with and without the device running .

The Results

The findings were clear: airKAVE significantly reduced the concentration of viable SARS-CoV-2 particles in the air compared to natural decay.

• After 15 minutes, viral reduction was measured at 80%.
• After 30 minutes, reduction reached 95%.
• After 45 minutes, the device achieved over 98% viral deactivation.
• By 60 minutes, efficacy was measured at 98.9% .

These results confirm that plasma-based air purification can neutralize airborne pathogens quickly and effectively, even in challenging conditions.

Why Plasma Technology Matters

Unlike traditional filters that capture particles but may not destroy them, plasma actively neutralizes airborne threats. By generating reactive species, plasma breaks down the outer structures of viruses and bacteria, rendering them non-infectious.

The MRIGlobal study validates that airKAVE’s Plascide® plasma platform is not just theory — it works against one of the most serious airborne pathogens of our time.

Building Safer Environments

At KAVE Industries, we view this as more than a single test. It’s part of a broader commitment to applying plasma technology across multiple domains:

• airKAVE: clean air and protection in occupied spaces.
• earthKAVE: plasma for surfaces, infrastructure, and environmental safety.
• fireKAVE: advancing toward energy and fusion applications.

The pandemic underscored how essential clean, safe air is to health and productivity. With independent testing like this, we can show that plasma technology is not just the future — it’s here today.

Full MRIGlobal Report: Download the PDF

‍